Found: 30
Select item for more details and to access through your institution.
<sup>18</sup>F-FDG and <sup>18</sup>F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091387
- By:
- Publication type:
- Article
[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053410
- By:
- Publication type:
- Article
Single-voxel delay map from long-axial field-of-view PET scans.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360326
- By:
- Publication type:
- Article
Single-voxel delay map from long-axial field-of-view PET scans.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360326
- By:
- Publication type:
- Article
A convolutional neural network for total tumor segmentation in [<sup>64</sup>Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms.
- Published in:
- EJNMMI Research, 2022, v. 12, p. 1, doi. 10.1186/s13550-022-00901-2
- By:
- Publication type:
- Article
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1, doi. 10.2967/jnumed.124.267939
- By:
- Publication type:
- Article
Semi‐automatic tumor delineation for evaluation of <sup>64</sup>Cu‐DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi‐automatic tumor delineation for evaluation of <sup>64</sup>Cu‐ DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi‐automatic tumor delineation for evaluation of <sup>64</sup>Cu‐ DOTATATE PET/CT in patientswith neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi-automatic tumor delineation for evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi-automatic tumor delineation for evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi-automatic tumor delineation for evaluation of <sup>64</sup>Cu- DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi-automatic tumor delineation for evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
Semi-automatic tumor delineation for evaluation of <sup>64</sup>Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258392
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244798
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression2 free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244798
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression - free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244798
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression2 free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240143
- By:
- Publication type:
- Article
<sup>64</sup>Cu-DOTATATE PET/CT and prediction of overall and progression free survival in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.24014
- By:
- Publication type:
- Article
Detection of Pulmonary Embolism with Combined Ventilation-Perfusion SPECT and Low-Dose CT: Head-to-Head Comparison with Multidetector CT Angiography.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 12, p. 1987, doi. 10.2967/jnumed.108.061606
- By:
- Publication type:
- Article
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-168
- By:
- Publication type:
- Article
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.
- Published in:
- 2013
- By:
- Publication type:
- journal article